Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
27 Leser
Artikel bewerten:
(0)

Animal Medication - Global Strategic Business Report

DUBLIN, Jan. 02, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/ss6rxq/animal_medication) has announced the addition of the "Animal Medication - Global Strategic Business Report" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This report analyzes the worldwide markets for Animal Medication in US$ Million by the following Product Segments:

  • Parasiticides
  • Vaccines
  • Anti-Infectives
  • Medicinal Feed Additives
  • Others

The report also analyzes the following End-Use Segments: Companion Animals, and Farm Animals.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 122 companies including many key and niche players such as -

  • Abbott Animal Health
  • Bayer HealthCare
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale S.A
  • Dechra Pharmaceuticals PLC

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions And Scope of Study

II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
2. GROWTH DRIVERS AND MARKET TRENDS
3. PRODUCT OVERVIEW
4. PRODUCT LAUNCHES/INTRODUCTIONS
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Animal Health (USA)
  • Bayer HealthCare (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale S.A. (France)
  • Dechra Pharmaceuticals PLC (UK)
  • Eli Lilly and Company (USA)
  • Merck Animal Health (Netherlands)
  • Merial Limited (USA)
  • Novartis Animal Health, Inc. (USA)
  • Vetericyn, Inc. (USA)
  • Vétoquinol SA (France)
  • Virbac SA (France)
  • Zoetis, Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE

III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. LATIN AMERICA
7. REST OF WORLD

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 122 (including Divisions/Subsidiaries 144)

  • The United States (62)
  • Canada (3)
  • Japan (1)
  • Europe (37)
  • France (4)
  • Germany (7)
  • The United Kingdom (7)
  • Italy (2)
  • Rest of Europe (17)
  • Asia-Pacific (Excluding Japan) (30)
  • Latin America (5)
  • Africa (2)
  • Middle East (4)

For more information visit http://www.researchandmarkets.com/research/ss6rxq/animal_medication

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.